Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Catalent
Pharma
Catalent reorg leaves 300 without jobs as CDMO awaits buyout
Even as Catalent moves toward a sale to Novo Holdings, the company revealed that it's trimmed hundreds of jobs in recent months.
Fraiser Kansteiner
Feb 15, 2024 8:45am
Catalent's sales continue to be plagued by low COVID demand
Feb 9, 2024 9:55am
Catalent's Indiana filling plant in hot water with the FDA again
Feb 7, 2024 2:11pm
Amid GLP-1 supply constraints, Lilly to prep for orals 'at risk'
Feb 6, 2024 2:36pm
Novo Holdings pays $16.5B to scoop up CDMO giant Catalent
Feb 5, 2024 10:22am
With record year, Samsung Bio bucks CDMO industry's tough 2023
Jan 25, 2024 10:33am